THERAVANCE BIOPHARMA, INC. (a Cayman Islands exempted company) $200,000,000 3.250% Convertible Senior Notes due 2023 UNDERWRITING AGREEMENTUnderwriting Agreement • November 2nd, 2016 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 2nd, 2016 Company Industry Jurisdiction